{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:00:28Z","timestamp":1754107228515,"version":"3.40.3"},"publisher-location":"Cham","reference-count":253,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030807580"},{"type":"electronic","value":"9783030807597"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/7854_2019_126","type":"book-chapter","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T17:02:50Z","timestamp":1581354170000},"page":"3-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment"],"prefix":"10.1007","author":[{"given":"Thomas A.","family":"Angelovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa J.","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwina J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce J.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"issue":"3","key":"126_CR1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13365-016-0505-9","volume":"23","author":"M Abassi","year":"2017","unstructured":"Abassi M, Morawski BM, Nakigozi G, Nakasujja N, Kong X, Meya DB et al (2017) Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda. J Neurovirol 23(3):369\u2013375","journal-title":"J Neurovirol"},{"issue":"3","key":"126_CR3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/649899","volume":"201","author":"BM Ances","year":"2010","unstructured":"Ances BM, Vaida F, Yeh MJ, Liang CL, Buxton RB, Letendre S et al (2010) HIV and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis 201(3):336\u2013340","journal-title":"J Infect Dis"},{"issue":"6","key":"126_CR4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002516","volume":"3","author":"P Ancuta","year":"2008","unstructured":"Ancuta P, Kamat A, Kunstman KJ, Kim E-Y, Autissier P, Wurcel A et al (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3(6):e2516","journal-title":"PLoS One"},{"issue":"5","key":"126_CR5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s13365-015-0359-6","volume":"21","author":"AM Anderson","year":"2015","unstructured":"Anderson AM, Fennema-Notestine C, Umlauf A, Taylor MJ, Clifford DB, Marra CM et al (2015) CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease. J Neurovirol 21(5):559\u2013567","journal-title":"J Neurovirol"},{"key":"126_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiw505","volume":"215","author":"AM Anderson","year":"2017","unstructured":"Anderson AM, Mu\u00f1oz-Moreno JA, McClernon D, Ellis RJ, Cookson D, Clifford DB et al (2017) Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy. J Infect Dis 215:105\u2013113","journal-title":"J Infect Dis"},{"key":"126_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2018.03.007","volume":"319","author":"AM Anderson","year":"2018","unstructured":"Anderson AM, Croteau D, Ellis RJ, Rosario D, Potter M, Guillemin GJ et al (2018) HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau. J Neuroimmunol 319:13\u201318","journal-title":"J Neuroimmunol"},{"issue":"1","key":"126_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/QAI.0000000000000559","volume":"69","author":"TA Angelovich","year":"2015","unstructured":"Angelovich TA, Hearps AC, Maisa A, Martin GE, Lichtfuss GF, Cheng W-J et al (2015) Viremic and virologically suppressed HIV infection increases age-related changes to monocyte activation equivalent to 12 and 4 years of aging, respectively. J Acquir Immune Defic Syndr 69(1):11\u201317","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"18","key":"126_CR9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker J, Brew B, Byrd D, Cherner M et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789\u20131799","journal-title":"Neurology"},{"issue":"13","key":"126_CR10","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0000000000001160","volume":"30","author":"EL Asahchop","year":"2016","unstructured":"Asahchop EL, Akinwumi SM, Branton WG, Fujiwara E, Gill MJ, Power C (2016) Plasma microRNA profiling predicts HIV-associated neurocognitive disorder. AIDS 30(13):2021\u20132031","journal-title":"AIDS"},{"issue":"1","key":"126_CR11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002327","volume":"95","author":"I Asher","year":"2016","unstructured":"Asher I, Guri KM, Elbirt D, Bezalel SR, Maldarelli F, Mor O et al (2016) Characteristics and outcome of patients diagnosed with HIV at older age. Medicine 95(1):e2327","journal-title":"Medicine"},{"key":"126_CR12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1743-422X-10-358","volume":"10","author":"A Bagashev","year":"2013","unstructured":"Bagashev A, Sawaya BE (2013) Roles and functions of HIV-1 Tat protein in the CNS: an overview. Virol J 10:358","journal-title":"Virol J"},{"issue":"17","key":"126_CR13","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1212\/WNL.0b013e3182a9565e","volume":"81","author":"VVR Bandaru","year":"2013","unstructured":"Bandaru VVR, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S et al (2013) A lipid storage\u2013like disorder contributes to cognitive decline in HIV-infected subjects. Neurology 81(17):1492\u20131499","journal-title":"Neurology"},{"issue":"2","key":"126_CR14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/mol.115.098590","volume":"88","author":"L Bertrand","year":"2015","unstructured":"Bertrand L, Toborek M (2015) Dysregulation of endoplasmic reticulum stress and autophagic responses by the antiretroviral drug efavirenz. Mol Pharmacol 88(2):304\u2013315","journal-title":"Mol Pharmacol"},{"issue":"2","key":"126_CR15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.21225","volume":"63","author":"K Bhaskaran","year":"2008","unstructured":"Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C et al (2008) Changes in the incidence and predictors of human immunodeficiency virus\u2013associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 63(2):213\u2013221","journal-title":"Ann Neurol"},{"issue":"10","key":"126_CR16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1258\/ijsa.2011.010507","volume":"22","author":"R Bingham","year":"2011","unstructured":"Bingham R, Ahmed N, Rangi P, Johnson M, Tyrer M, Green J (2011) HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Int J STD AIDS 22(10):608\u2013609","journal-title":"Int J STD AIDS"},{"issue":"10","key":"126_CR17","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1007\/s00330-017-4772-5","volume":"27","author":"J Boban","year":"2017","unstructured":"Boban J, Kozic D, Turkulov V, Ostojic J, Semnic R, Lendak D et al (2017) HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naive and treated patients. Eur Radiol 27(10):4218\u20134236","journal-title":"Eur Radiol"},{"issue":"11","key":"126_CR18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/infdis\/jir134","volume":"203","author":"DR Boulware","year":"2011","unstructured":"Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, French MA et al (2011) Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis 203(11):1637\u20131646","journal-title":"J Infect Dis"},{"issue":"6","key":"126_CR19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","volume":"200","author":"JM Brenchley","year":"2004","unstructured":"Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ et al (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200(6):749\u2013759","journal-title":"J Exp Med"},{"issue":"12","key":"126_CR20","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S et al (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12(12):1365\u20131371","journal-title":"Nat Med"},{"issue":"4","key":"126_CR21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ana.410280413","volume":"28","author":"BJ Brew","year":"1990","unstructured":"Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, Schwartz MK et al (1990) Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 28(4):556\u2013560","journal-title":"Ann Neurol"},{"issue":"4","key":"126_CR22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410380404","volume":"38","author":"BJ Brew","year":"1995","unstructured":"Brew BJ, Rosenblum M, Cronin K, Price RW (1995) AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 38(4):563\u2013570","journal-title":"Ann Neurol"},{"issue":"2","key":"126_CR23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/infdis\/174.2.294","volume":"174","author":"BJ Brew","year":"1996","unstructured":"Brew BJ, Dunbar N, Pemberton L, Kaldor J (1996) Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of \u03b22-microglobulin and neopterin. J Infect Dis 174(2):294\u2013298","journal-title":"J Infect Dis"},{"issue":"4","key":"126_CR24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/514001","volume":"175","author":"BJ Brew","year":"1997","unstructured":"Brew BJ, Pemberton L, Cunningham P, Law MG (1997) Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 175(4):963\u2013966","journal-title":"J Infect Dis"},{"issue":"9","key":"126_CR25","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","volume":"65","author":"BJ Brew","year":"2005","unstructured":"Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L (2005) CSF amyloid \u03b242 and tau levels correlate with AIDS dementia complex. Neurology 65(9):1490\u20131492","journal-title":"Neurology"},{"issue":"4","key":"126_CR26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s13365-011-0035-4","volume":"17","author":"A Brown","year":"2011","unstructured":"Brown A, Islam T, Adams R, Nerle S, Kamara M, Eger C et al (2011) Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals. J Neurovirol 17(4):382\u2013392","journal-title":"J Neurovirol"},{"issue":"9","key":"126_CR27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","volume":"22","author":"KM Bruner","year":"2016","unstructured":"Bruner KM, Murray AJ, Pollack RA, Soliman MG, Laskey SB, Capoferri AA et al (2016) Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med 22(9):1043\u20131049","journal-title":"Nat Med"},{"issue":"6","key":"126_CR28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/aid.2015.0328","volume":"32","author":"SJ Brunt","year":"2016","unstructured":"Brunt SJ, Cysique LA, Lee S, Burrows S, Brew BJ, Price P (2016) Short communication: do cytomegalovirus antibody levels associate with age-related syndromes in HIV patients stable on antiretroviral therapy? AIDS Res Hum Retrovir 32(6):567\u2013572","journal-title":"AIDS Res Hum Retrovir"},{"issue":"7","key":"126_CR29","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/infdis\/jix662","volume":"217","author":"PD Burbelo","year":"2018","unstructured":"Burbelo PD, Price RW, Hagberg L, Hatano H, Spudich S, Deeks SG et al (2018) Anti-human immunodeficiency virus antibodies in the cerebrospinal fluid: evidence of early treatment impact on central nervous system reservoir? J Infect Dis 217(7):1024\u20131032","journal-title":"J Infect Dis"},{"issue":"4","key":"126_CR30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000842","volume":"6","author":"TH Burdo","year":"2010","unstructured":"Burdo TH, Soulas C, Orzechowski K, Button J, Krishnan A, Sugimoto C et al (2010) Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 6(4):e1000842","journal-title":"PLoS Pathog"},{"issue":"1","key":"126_CR31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12068","volume":"254","author":"TH Burdo","year":"2013","unstructured":"Burdo TH, Lackner A, Williams KC (2013a) Monocyte\/macrophages and their role in HIV neuropathogenesis. Immunol Rev 254(1):102\u2013113","journal-title":"Immunol Rev"},{"issue":"9","key":"126_CR32","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/QAD.0b013e32836010bd","volume":"27","author":"TH Burdo","year":"2013","unstructured":"Burdo TH, Weiffenbach A, Woods SP, Letendre S, Ellis RJ, Williams KC (2013b) Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS (London, England) 27(9):1387\u20131395","journal-title":"AIDS (London, England)"},{"issue":"5","key":"126_CR33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","volume":"50","author":"A Canestri","year":"2010","unstructured":"Canestri A, Lescure F-X, Jaureguiberry S, Moulignier A, Amiel C, Marcelin A et al (2010) Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis 50(5):773\u2013778","journal-title":"Clin Infect Dis"},{"issue":"4","key":"126_CR34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/13550280902973960","volume":"15","author":"VA Cardenas","year":"2009","unstructured":"Cardenas VA, Meyerhoff DJ, Studholme C, Kornak J, Rothlind J, Lampiris H et al (2009) Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol 15(4):324\u2013333","journal-title":"J Neurovirol"},{"issue":"3","key":"126_CR35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13365-015-0404-5","volume":"22","author":"A Carvalhal","year":"2016","unstructured":"Carvalhal A, Gill MJ, Letendre SL, Rachlis A, Bekele T, Raboud J et al (2016) Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study. J Neurovirol 22(3):349\u2013357","journal-title":"J Neurovirol"},{"issue":"11","key":"126_CR36","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/QAD.0000000000000303","volume":"28","author":"E Cassol","year":"2014","unstructured":"Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D (2014) Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS 28(11):1579\u20131591","journal-title":"AIDS"},{"unstructured":"Centers for Disease Control and Prevention (2017) HIV Surveillance Report, 2016, vol 28. http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Accessed 2 May 2018","key":"126_CR37"},{"doi-asserted-by":"crossref","unstructured":"Chaganti J, Marripundi K, Staub LP, Rae CD, Gates T, Moffat KJ et al (2019) Imaging correlates of the Blood Brain Barrier disruption in HIV associated neurocognitive disorder and therapeutic implications. AIDS 33(12):1843\u20131852","key":"126_CR38","DOI":"10.1097\/QAD.0000000000002300"},{"issue":"6","key":"126_CR39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/aid.2012.0229","volume":"29","author":"S Chiao","year":"2013","unstructured":"Chiao S, Rosen HJ, Nicolas K, Wendelken LA, Alcantar O, Rankin KP et al (2013) Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Res Hum Retrovir 29(6):949\u2013956","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"126_CR40","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/brain\/awy339","volume":"142","author":"HJ Cho","year":"2019","unstructured":"Cho HJ, Bertrand L, Toborek M (2019) Blood\u2013brain barrier pericytes as a target for HIV-1 infection. Brain 142(3):502\u2013511","journal-title":"Brain"},{"issue":"2","key":"126_CR41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.21697","volume":"66","author":"MJ Churchill","year":"2009","unstructured":"Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ et al (2009) Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 66(2):253\u2013258","journal-title":"Ann Neurol"},{"key":"126_CR42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrmicro.2015.5","volume":"14","author":"MJ Churchill","year":"2015","unstructured":"Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R (2015) HIV reservoirs: what, where and how to target them. Nat Rev Microbiol 14:55","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"126_CR43","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s15010-013-0503-2","volume":"41","author":"N Ciccarelli","year":"2013","unstructured":"Ciccarelli N, Fabbiani M, Grima P, Falasca K, Tana M, Baldonero E et al (2013) Comparison of cognitive performance in HIV or HCV mono-infected and HIV\u2013HCV co-infected patients. Infection 41(6):1103\u20131109","journal-title":"Infection"},{"issue":"23","key":"126_CR44","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","volume":"73","author":"DB Clifford","year":"2009","unstructured":"Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR et al (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73(23):1982\u20131987","journal-title":"Neurology"},{"issue":"3","key":"126_CR45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAI.0000000000001489","volume":"76","author":"KM Clifford","year":"2017","unstructured":"Clifford KM, Samboju V, Cobigo Y, Milanini B, Marx GA, Hellmuth JM et al (2017) Progressive brain atrophy despite persistent viral suppression in HIV patients older than 60 years. J Acquir Immune Defic Syndr 76(3):289\u2013297","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"14","key":"126_CR46","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1212\/WNL.0000000000003790","volume":"88","author":"JH Cole","year":"2017","unstructured":"Cole JH, Underwood J, Caan MWA, De Francesco D, van Zoest RA, Leech R et al (2017) Increased brain-predicted aging in treated HIV disease. Neurology 88(14):1349\u20131357","journal-title":"Neurology"},{"issue":"6","key":"126_CR47","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1073\/pnas.95.6.3117","volume":"95","author":"K Conant","year":"1998","unstructured":"Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C et al (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A 95(6):3117\u20133121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"126_CR48","doi-asserted-by":"crossref","DOI":"10.1038\/srep33310","volume":"6","author":"MJ Corley","year":"2016","unstructured":"Corley MJ, Dye C, D\u2019Antoni ML, Byron MM, Yo KL-A, Lum-Jones A et al (2016) Comparative DNA methylation profiling reveals an immunoepigenetic signature of HIV-related cognitive impairment. Sci Rep 6:33310","journal-title":"Sci Rep"},{"issue":"2","key":"126_CR49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s13365-011-0021-x","volume":"17","author":"LA Cysique","year":"2011","unstructured":"Cysique LA, Brew BJ (2011) Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol 17(2):176\u2013183","journal-title":"J Neurovirol"},{"issue":"6","key":"126_CR50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","volume":"10","author":"LA Cysique","year":"2004","unstructured":"Cysique LA, Maruff P, Brew BJ (2004) Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol 10(6):350\u2013357","journal-title":"J Neurovirol"},{"issue":"5","key":"126_CR51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","volume":"73","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP et al (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73(5):342\u2013348","journal-title":"Neurology"},{"issue":"4","key":"126_CR52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120488","volume":"10","author":"LA Cysique","year":"2015","unstructured":"Cysique LA, Hey-Cunningham WJ, Dermody N, Chan P, Brew BJ, Koelsch KK (2015a) Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition. PLoS One 10(4):e0120488","journal-title":"PLoS One"},{"key":"126_CR53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12883-015-0298-0","volume":"15","author":"LA Cysique","year":"2015","unstructured":"Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CSN et al (2015b) APOE \u03b54 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals \u2013 a cross-sectional observational study. BMC Neurol 15:51","journal-title":"BMC Neurol"},{"issue":"3","key":"126_CR54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/QAD.0000000000002076","volume":"33","author":"LA Cysique","year":"2019","unstructured":"Cysique LA, Juge L, Lennon MJ, Gates TM, Jones SP, Lovelace MD et al (2019) HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection. AIDS 33(3):433\u2013441","journal-title":"AIDS"},{"issue":"1","key":"126_CR55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/QAI.0000000000001752","volume":"79","author":"ML D\u2019Antoni","year":"2018","unstructured":"D\u2019Antoni ML, Paul RH, Mitchell BI, Kohorn L, Fischer L, Lefebvre E et al (2018) Improved cognitive performance and reduced monocyte activation in virally suppressed chronic HIV after dual CCR2 and CCR5 antagonism. J Acquir Immune Defic Syndr 79(1):108\u2013116","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"15","key":"126_CR56","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/QAD.0000000000000400","volume":"28","author":"V Dahl","year":"2014","unstructured":"Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW (2014) Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS 28(15):2251\u20132258","journal-title":"AIDS"},{"key":"126_CR57","volume":"5","author":"MF de Oliveira","year":"2015","unstructured":"de Oliveira MF, Murrell B, P\u00e9rez-Santiago J, Vargas M, Ellis RJ, Letendre S et al (2015) Circulating HIV DNA correlates with neurocognitive impairment in older HIV-infected adults on suppressive ART. Sci Rep 5:17094","journal-title":"Sci Rep"},{"issue":"4","key":"126_CR58","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","volume":"104","author":"SG Deeks","year":"2004","unstructured":"Deeks SG, Kitchen CMR, Liu L, Guo H, Gascon R, Narv\u00e1ez AB et al (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104(4):942\u2013947","journal-title":"Blood"},{"issue":"15","key":"126_CR59","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1212\/WNL.0b013e31828c2e9e","volume":"80","author":"P Desplats","year":"2013","unstructured":"Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S et al (2013) Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 80(15):1415\u20131423","journal-title":"Neurology"},{"key":"126_CR60","volume":"7","author":"AM Dickens","year":"2017","unstructured":"Dickens AM, Yoo SW, Chin AC, Xu J, Johnson TP, Trout AL et al (2017) Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging. Sci Rep 7:7748","journal-title":"Sci Rep"},{"issue":"01","key":"126_CR61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4236\/wja.2017.71006","volume":"7","author":"AF dos Santos-Silva","year":"2017","unstructured":"dos Santos-Silva AF, Alves JMF, Ramos I, del C\u00e1rmen Pi\u00f1eiro-Calvo M, Sousa C, do Ros\u00e1rio Serr\u00e3o M et al (2017) Neurocognitive disorders in patients with HIV infection with virologic suppression for more than 10 years. World J AIDS 7(01):59","journal-title":"World J AIDS"},{"issue":"4","key":"126_CR62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13365-015-0334-2","volume":"21","author":"JL Drewes","year":"2015","unstructured":"Drewes JL, Meulendyke KA, Liao Z, Witwer KW, Gama L, Ubaida-Mohien C et al (2015) Quinolinic acid\/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART. J Neurovirol 21(4):449\u2013463","journal-title":"J Neurovirol"},{"issue":"12","key":"126_CR63","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1086\/523648","volume":"196","author":"A Eden","year":"2007","unstructured":"Eden A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslen M (2007) Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis 196(12):1779\u20131783","journal-title":"J Infect Dis"},{"issue":"12","key":"126_CR64","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/infdis\/jiw454","volume":"214","author":"A Eden","year":"2016","unstructured":"Eden A, Nilsson S, Hagberg L, Fuchs D, Zetterberg H, Svennerholm B et al (2016) Asymptomatic cerebrospinal fluid HIV-1 viral blips and viral escape during antiretroviral therapy: a longitudinal study. J Infect Dis 214(12):1822\u20131825","journal-title":"J Infect Dis"},{"issue":"3","key":"126_CR65","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jcp.21452","volume":"216","author":"D Eletto","year":"2008","unstructured":"Eletto D, Russo G, Passiatore G, Valle LD, Giordano A, Khalili K et al (2008) Inhibition of SNAP25 expression by HIV-1 Tat Involves the activity of mir-128a. J Cell Physiol 216(3):764\u2013770","journal-title":"J Cell Physiol"},{"issue":"10","key":"126_CR66","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.4049\/jimmunol.178.10.6581","volume":"178","author":"PJ Ellery","year":"2007","unstructured":"Ellery PJ, Tippett E, Chiu Y-L, Paukovics G, Cameron PU, Solomon A et al (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178(10):6581\u20136589","journal-title":"J Immunol"},{"issue":"4","key":"126_CR67","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archneur.1997.00550160054016","volume":"54","author":"RJ Ellis","year":"1997","unstructured":"Ellis RJ, Deutsch R, Heaton RK et al (1997) Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch Neurol 54(4):416\u2013424","journal-title":"Arch Neurol"},{"issue":"6","key":"126_CR68","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archneur.59.6.923","volume":"59","author":"RJ Ellis","year":"2002","unstructured":"Ellis RJ, Moore DJ, Childers ME et al (2002) Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 59(6):923\u2013928","journal-title":"Arch Neurol"},{"issue":"14","key":"126_CR69","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/QAD.0b013e32834a40cd","volume":"25","author":"RJ Ellis","year":"2011","unstructured":"Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D et al (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25(14):1747\u20131751","journal-title":"AIDS"},{"issue":"7","key":"126_CR70","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/cid\/cit921","volume":"58","author":"RJ Ellis","year":"2014","unstructured":"Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N et al (2014) Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis 58(7):1015\u20131022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"126_CR71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001052","volume":"6","author":"JD Estes","year":"2010","unstructured":"Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, Paiardini M et al (2010) Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 6(8):e1001052","journal-title":"PLoS Pathog"},{"key":"126_CR72","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.4411","volume":"23","author":"JD Estes","year":"2017","unstructured":"Estes JD, Kityo C, Ssali F, Swainson L, Makamdop KN, Del Prete GQ et al (2017) Defining total-body AIDS-virus burden with implications for curative strategies. Nat Med 23:1271\u20131276","journal-title":"Nat Med"},{"issue":"2","key":"126_CR73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAD.0000000000000892","volume":"30","author":"TH Evering","year":"2016","unstructured":"Evering TH, Applebaum A, La Mar M, Garmon D, Dorfman D, Markowitz M (2016) Rates of non-confounded HIV associated neurocognitive disorders in men initiating cART during primary infection. AIDS 30(2):203\u2013210","journal-title":"AIDS"},{"issue":"6","key":"126_CR74","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","volume":"11","author":"MS Fiandaca","year":"2015","unstructured":"Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB et al (2015) Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement 11(6):600\u20137.e1","journal-title":"Alzheimers Dement"},{"issue":"6","key":"126_CR75","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/135502801753248114","volume":"7","author":"T Fischer-Smith","year":"2001","unstructured":"Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L\u2019Heureux D, R\u00e9gulier EG et al (2001) CNS invasion by CD14+\/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 7(6):528\u2013541","journal-title":"J Neurovirol"},{"issue":"1","key":"126_CR76","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s13365-014-0296-9","volume":"21","author":"GB Fogel","year":"2015","unstructured":"Fogel GB, Lamers SL, Levine AJ, Valdes-Sueiras M, McGrath MS, Shapshak P et al (2015) Factors related to HIV-associated neurocognitive impairment differ with age. J Neurovirol 21(1):56\u201365","journal-title":"J Neurovirol"},{"issue":"9","key":"126_CR77","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/infdis\/jiu273","volume":"210","author":"HA Funes","year":"2014","unstructured":"Funes HA, Apostolova N, Alegre F, Blas-Garcia A, Alvarez A, Marti-Cabrera M et al (2014) Neuronal bioenergetics and acute mitochondrial dysfunction: a clue to understanding the central nervous system side effects of efavirenz. J Infect Dis 210(9):1385\u20131395","journal-title":"J Infect Dis"},{"issue":"8","key":"126_CR78","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/jac\/dkv098","volume":"70","author":"HA Funes","year":"2015","unstructured":"Funes HA, Blas-Garcia A, Esplugues JV, Apostolova N (2015) Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines. J Antimicrob Chemother 70(8):2249\u20132254","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"126_CR79","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.aids.0000432467.54003.f7","volume":"28","author":"LJ Garvey","year":"2014","unstructured":"Garvey LJ, Pavese N, Politis M, Ramlackhansingh A, Brooks DJ, Taylor-Robinson SD et al (2014) Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS 28(1):67\u201372","journal-title":"AIDS"},{"issue":"4","key":"126_CR80","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/QAD.0000000000000951","volume":"30","author":"TM Gates","year":"2016","unstructured":"Gates TM, Cysique LA, Siefried KJ, Chaganti J, Moffat KJ, Brew BJ (2016) Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder. AIDS 30(4):591\u2013600","journal-title":"AIDS"},{"issue":"2","key":"126_CR81","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11904-015-0266-8","volume":"12","author":"BB Gelman","year":"2015","unstructured":"Gelman BB (2015) Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered. Curr HIV\/AIDS Rep 12(2):272\u2013279","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"9","key":"126_CR82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046178","volume":"7","author":"BB Gelman","year":"2012","unstructured":"Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM et al (2012) The national NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One 7(9):e46178","journal-title":"PLoS One"},{"issue":"2","key":"126_CR83","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ana.25160","volume":"83","author":"SD Ginsberg","year":"2018","unstructured":"Ginsberg SD, Alldred MJ, Gunnam SM, Schiroli C, Lee SH, Morgello S et al (2018) Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis. Ann Neurol 83(2):406\u2013417","journal-title":"Ann Neurol"},{"issue":"12","key":"126_CR84","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/518043","volume":"195","author":"M Gissl\u00e9n","year":"2007","unstructured":"Gissl\u00e9n M, Hagberg L, Brew BJ, Cinque P, Price RW, Rosengren L (2007) Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis 195(12):1774\u20131778","journal-title":"J Infect Dis"},{"key":"126_CR85","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","volume":"3","author":"M Gissl\u00e9n","year":"2015","unstructured":"Gissl\u00e9n M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L et al (2015) Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine 3:135\u2013140","journal-title":"EBioMedicine"},{"issue":"6","key":"126_CR86","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/jir.2015.0177","volume":"36","author":"JD Glenn","year":"2016","unstructured":"Glenn JD, Mowry EM (2016) Emerging concepts on the gut microbiome and multiple sclerosis. J Interf Cytokine Res 36(6):347\u2013357","journal-title":"J Interf Cytokine Res"},{"issue":"9","key":"126_CR87","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2352-3018(17)30098-X","volume":"4","author":"K Goodkin","year":"2017","unstructured":"Goodkin K, Miller EN, Cox C, Reynolds S, Becker JT, Martin E et al (2017) Effect of aging on neurocognitive function by stage of HIV infection: evidence from the Multi-Center AIDS Cohort Study. Lancet HIV 4(9):e411\u2013ee22","journal-title":"Lancet HIV"},{"issue":"21","key":"126_CR88","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.1128\/JVI.75.21.10073-10089.2001","volume":"75","author":"PR Gorry","year":"2001","unstructured":"Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, Birch CJ et al (2001) Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 75(21):10073\u201310089","journal-title":"J Virol"},{"issue":"9320","key":"126_CR89","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/S0140-6736(02)08681-6","volume":"359","author":"PR Gorry","year":"2002","unstructured":"Gorry PR, Zhang C, Wu S, Kunstman K, Trachtenberg E, Phair J et al (2002) Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele. Lancet 359(9320):1832\u20131834","journal-title":"Lancet"},{"issue":"3","key":"126_CR90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171887","volume":"12","author":"C Gott","year":"2017","unstructured":"Gott C, Gates T, Dermody N, Brew BJ, Cysique LA (2017) Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity. PLoS One 12(3):e0171887","journal-title":"PLoS One"},{"key":"126_CR91","volume":"3","author":"M-L Gougeon","year":"2017","unstructured":"Gougeon M-L, Poirier-Beaudouin B, Durant J, Lebrun-Frenay C, Sa\u00efdi H, Seffer V et al (2017) HMGB1\/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND). Heliyon 3:e00245","journal-title":"Heliyon"},{"issue":"23","key":"126_CR92","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","volume":"82","author":"I Grant","year":"2014","unstructured":"Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ et al (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 82(23):2055\u20132062","journal-title":"Neurology"},{"issue":"4","key":"126_CR93","volume":"8","author":"LR Gray","year":"2013","unstructured":"Gray LR, Tachedjian G, Ellett AM, Roche MJ, Cheng WJ, Guillemin GJ et al (2013) The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes. PLoS One 8(4):e62196","journal-title":"PLoS One"},{"issue":"2","key":"126_CR94","volume":"9","author":"LR Gray","year":"2014","unstructured":"Gray LR, Turville SG, Hitchen TL, Cheng W-J, Ellett AM, Salimi H et al (2014) HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles. PLoS One 9(2):e90620","journal-title":"PLoS One"},{"issue":"4","key":"126_CR95","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/mp.2015.111","volume":"21","author":"LR Gray","year":"2016","unstructured":"Gray LR, Cowley D, Welsh C, Lu HK, Brew BJ, Lewin SR et al (2016) CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies. Mol Psychiatry 21(4):574\u2013584","journal-title":"Mol Psychiatry"},{"issue":"4","key":"126_CR96","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","volume":"19","author":"DA Green","year":"2005","unstructured":"Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19(4):407\u2013411","journal-title":"AIDS"},{"issue":"11","key":"126_CR97","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","volume":"53","author":"G Guaraldi","year":"2011","unstructured":"Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E et al (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53(11):1120\u20131126","journal-title":"Clin Infect Dis"},{"issue":"1","key":"126_CR98","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1742-2094-9-138","volume":"9","author":"D Guha","year":"2012","unstructured":"Guha D, Nagilla P, Redinger C, Srinivasan A, Schatten GP, Ayyavoo V (2012) Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells. J Neuroinflammation 9(1):138","journal-title":"J Neuroinflammation"},{"key":"126_CR99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","volume":"7","author":"L Hagberg","year":"2010","unstructured":"Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A et al (2010) Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 7:15","journal-title":"AIDS Res Ther"},{"issue":"2","key":"126_CR100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.1991.4.123","volume":"4","author":"S Haggerty","year":"1991","unstructured":"Haggerty S, Stevenson M (1991) Predominance of distinct viral genotypes in brain and lymph node compartments of HIV-1-infected individuals. Viral Immunol 4(2):123\u2013131","journal-title":"Viral Immunol"},{"key":"126_CR101","volume":"6","author":"XP Hao","year":"2015","unstructured":"Hao XP, Lucero CM, Turkbey B, Bernardo ML, Morcock DR, Deleage C et al (2015) Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection. Nat Commun 6:8020","journal-title":"Nat Commun"},{"issue":"5","key":"126_CR102","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/QAD.0b013e3283427da7","volume":"25","author":"J Harezlak","year":"2011","unstructured":"Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar ES et al (2011) Persistence of HIV\u2212 associated cognitive impairment, inflammation and neuronal injury in era of highly active antiretroviral treatment. AIDS 25(5):625\u2013633","journal-title":"AIDS"},{"issue":"4","key":"126_CR103","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1046\/j.1471-4159.1999.0731363.x","volume":"73","author":"NJ Haughey","year":"1999","unstructured":"Haughey NJ, Holden CP, Nath A, Geiger JD (1999) Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat. J Neurochem 73(4):1363\u20131374","journal-title":"J Neurochem"},{"issue":"13","key":"126_CR104","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","volume":"17","author":"MD Hazenberg","year":"2003","unstructured":"Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM et al (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17(13):1881\u20131888","journal-title":"AIDS"},{"issue":"23","key":"126_CR105","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"R Heaton","year":"2010","unstructured":"Heaton R, Clifford D, Franklin D, Woods S, Ake C, Vaida F et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study. Neurology 75(23):2087\u20132096","journal-title":"Neurology"},{"issue":"1","key":"126_CR106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17(1):3\u201316","journal-title":"J Neurovirol"},{"issue":"3","key":"126_CR107","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu862","volume":"60","author":"RK Heaton","year":"2015","unstructured":"Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K et al (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60(3):473\u2013480","journal-title":"Clin Infect Dis"},{"issue":"2","key":"126_CR108","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.0000000000002837","volume":"87","author":"J Hellmuth","year":"2016","unstructured":"Hellmuth J, Fletcher JLK, Valcour V, Kroon E, Ananworanich J, Intasan J et al (2016) Neurologic signs and symptoms frequently manifest in acute HIV infection. Neurology 87(2):148\u2013154","journal-title":"Neurology"},{"issue":"6","key":"126_CR109","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ana.410270614","volume":"27","author":"MP Heyes","year":"1990","unstructured":"Heyes MP, Mefford IN, Quearry BJ, Dedhia M, Lackner A (1990) Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status. Ann Neurol 27(6):666\u2013675","journal-title":"Ann Neurol"},{"issue":"12","key":"126_CR110","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000038347.48137.67","volume":"59","author":"C Hinkin","year":"2002","unstructured":"Hinkin C, Castellon S, Durvasula R, Hardy D, Lam M, Mason K et al (2002) Medication adherence among HIV+ adults effects of cognitive dysfunction and regimen complexity. Neurology 59(12):1944\u20131950","journal-title":"Neurology"},{"issue":"7","key":"126_CR111","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI98968","volume":"128","author":"JB Honeycutt","year":"2018","unstructured":"Honeycutt JB, Liao B, Nixon CC, Cleary RA, Thayer WO, Birath SL et al (2018) T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest 128(7):2862\u20132876","journal-title":"J Clin Invest"},{"issue":"1","key":"126_CR112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser MC, Tansey MG (2017) The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? NPJ Parkinsons Dis 3(1):3","journal-title":"NPJ Parkinsons Dis"},{"doi-asserted-by":"crossref","unstructured":"Hulgan T, Kallianpur AR, Guo Y, Barnholtz-Sloan JS, Gittleman H, Brown TT et al (2018) Peripheral blood mitochondrial DNA copy number obtained from genome-wide genotype data is associated with neurocognitive impairment in persons with chronic HIV infection. J Acquir Immune Defic Syndr 80(4):e95\u2013e102","key":"126_CR113","DOI":"10.1097\/QAI.0000000000001930"},{"issue":"1","key":"126_CR114","volume":"6","author":"PW Hunt","year":"2011","unstructured":"Hunt PW, Landay AL, Sinclair E, Martinson JA, Hatano H, Emu B et al (2011) A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One 6(1):e15924","journal-title":"PLoS One"},{"issue":"6","key":"126_CR115","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/JLB.3HI0118-015R","volume":"104","author":"M Jaureguiberry-Bravo","year":"2018","unstructured":"Jaureguiberry-Bravo M, Lopez L, Berman JW (2018) Frontline science: buprenorphine decreases CCL2-mediated migration of CD14+CD16+ monocytes. J Leukoc Biol 104(6):1049\u20131059","journal-title":"J Leukoc Biol"},{"issue":"11","key":"126_CR116","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/NEN.0000000000000255","volume":"74","author":"BK Jensen","year":"2015","unstructured":"Jensen BK, Monnerie H, Mannell MV, Gannon PJ, Espinoza CA, Erickson MA et al (2015) Altered oligodendrocyte maturation and myelin maintenance: the role of antiretrovirals in HIV-associated neurocognitive disorders. J Neuropathol Exp Neurol 74(11):1093\u20131118","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"126_CR117","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12879-016-1510-6","volume":"16","author":"S Jespersen","year":"2016","unstructured":"Jespersen S, Pedersen KK, Anesten B, Zetterberg H, Fuchs D, Gissl\u00e9n M et al (2016) Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study. BMC Infect Dis 16(1):176","journal-title":"BMC Infect Dis"},{"issue":"2","key":"126_CR118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088591","volume":"9","author":"J Jessen Krut","year":"2014","unstructured":"Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L et al (2014) Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One 9(2):e88591","journal-title":"PLoS One"},{"issue":"33","key":"126_CR119","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1073\/pnas.1308673110","volume":"110","author":"TP Johnson","year":"2013","unstructured":"Johnson TP, Patel K, Johnson KR, Maric D, Calabresi PA, Hasbun R et al (2013) Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci U S A 110(33):13588\u201313593","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"126_CR120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/QAD.0000000000000538","volume":"29","author":"U Jonathan","year":"2015","unstructured":"Jonathan U, Kevin RR, Alan W (2015) Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease? AIDS 29(3):253","journal-title":"AIDS"},{"key":"126_CR121","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/cid\/ciy1066","volume":"69","author":"SB Joseph","year":"2019","unstructured":"Joseph SB, Kincer LP, Bowman NM, Evans C, Vinikoor MJ, Lippincott CK et al (2019) HIV-1 RNA detected in the CNS after years of suppressive antiretroviral therapy can originate from a replicating CNS reservoir or clonally expanded cells. Clin Infect Dis 69:1345\u20131352","journal-title":"Clin Infect Dis"},{"issue":"4","key":"126_CR122","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jcp.25131","volume":"231","author":"F Kadri","year":"2016","unstructured":"Kadri F, LaPlante A, De Luca M, Doyle L, Velasco-Gonzalez C, Patterson JR et al (2016) Defining plasma microRNAs associated with cognitive impairment in HIV-infected patients. J Cell Physiol 231(4):829\u2013836","journal-title":"J Cell Physiol"},{"issue":"11","key":"126_CR123","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/QAD.0000000000000306","volume":"28","author":"KJ Kallianpur","year":"2014","unstructured":"Kallianpur KJ, Valcour VG, Lerdlum S, Busovaca E, Agsalda M, Sithinamsuwan P et al (2014) HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy. AIDS (London, England) 28(11):1619\u20131624","journal-title":"AIDS (London, England)"},{"issue":"2","key":"126_CR124","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx070","volume":"4","author":"S Kamal","year":"2017","unstructured":"Kamal S, Locatelli I, Wandeler G, Sehhat A, Bugnon O, Metral M et al (2017) The presence of human immunodeficiency virus-associated neurocognitive disorders is associated with a lower adherence to combined antiretroviral treatment. Open Forum Infect Dis 4(2):ofx070","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"126_CR125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/QAI.0b013e318256f3bc","volume":"60","author":"A Kamat","year":"2012","unstructured":"Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ et al (2012) Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 60(3):234\u2013243","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"8","key":"126_CR126","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1742-4658.2012.08500.x","volume":"279","author":"A Kandanearatchi","year":"2012","unstructured":"Kandanearatchi A, Brew BJ (2012) The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders. FEBS J 279(8):1366\u20131374","journal-title":"FEBS J"},{"issue":"3","key":"126_CR127","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2353\/ajpath.2006.050215","volume":"168","author":"WK Kim","year":"2006","unstructured":"Kim WK, Alvarez X, Fisher J, Bronfin B, Westmoreland S, McLaurin J et al (2006) CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am J Pathol 168(3):822\u2013834","journal-title":"Am J Pathol"},{"issue":"6","key":"126_CR128","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0000000000002150","volume":"33","author":"B-H Kim","year":"2019","unstructured":"Kim B-H, Kelschenbach J, Borjabad A, Hadas E, He H, Potash MJ et al (2019) Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice. AIDS 33(6):973\u2013984","journal-title":"AIDS"},{"issue":"1","key":"126_CR129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11481-018-9809-2","volume":"14","author":"A Ko","year":"2019","unstructured":"Ko A, Kang G, Hattler JB, Galadima HI, Zhang J, Li Q et al (2019) Macrophages but not astrocytes harbor HIV DNA in the brains of HIV-1-infected aviremic individuals on suppressive antiretroviral therapy. J Neuroimmune Pharmacol 14(1):110\u2013119","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"126_CR130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/21505594.2016.1212155","volume":"8","author":"JJ Krut","year":"2017","unstructured":"Krut JJ, Price RW, Zetterberg H, Fuchs D, Hagberg L, Yilmaz A et al (2017) No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau). Virulence 8(5):599\u2013604","journal-title":"Virulence"},{"issue":"10","key":"126_CR131","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","volume":"5","author":"LH Kuller","year":"2008","unstructured":"Kuller LH, Tracy R, Belloso W, Wit SD, Drummond F, Lane HC et al (2008) Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 5(10):e203","journal-title":"PLoS Med"},{"issue":"6","key":"126_CR132","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00415-010-5883-y","volume":"258","author":"M K\u00fcper","year":"2011","unstructured":"K\u00fcper M, Rabe K, Esser S, Gizewski ER, Husstedt IW, Maschke M et al (2011) Structural gray and white matter changes in patients with HIV. J Neurol 258(6):1066\u20131075","journal-title":"J Neurol"},{"key":"126_CR133","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1128\/JVI.00674-16","volume":"90","author":"SL Lamers","year":"2016","unstructured":"Lamers SL, Rose R, Maidji E, Agsalda-Garcia M, Nolan DJ, Fogel GB et al (2016) HIV DNA is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads. J Virol 90:8968\u20138983","journal-title":"J Virol"},{"issue":"7","key":"126_CR134","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/WNL.0b013e31820c3089","volume":"76","author":"E Lanoy","year":"2011","unstructured":"Lanoy E, Guiguet M, Bentata M, Rouveix E, Dhiver C, Poizot-Martin I et al (2011) Survival after neuroAIDS: association with antiretroviral CNS penetration-effectiveness score. Neurology 76(7):644\u2013651","journal-title":"Neurology"},{"issue":"1","key":"126_CR135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-2652-13-15","volume":"13","author":"K Lawler","year":"2010","unstructured":"Lawler K, Mosepele M, Ratcliffe S, Seloilwe E, Steele K, Nthobatsang R et al (2010) Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc 13(1):15","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"126_CR136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13365-010-0013-2","volume":"17","author":"SL Letendre","year":"2011","unstructured":"Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ et al (2011) Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. J Neurovirol 17(1):63\u201369","journal-title":"J Neurovirol"},{"issue":"5","key":"126_CR137","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/cid\/ciy170","volume":"67","author":"S Letendre","year":"2018","unstructured":"Letendre S, Bharti A, Perez-Valero I, Hanson B, Franklin D, Woods SP et al (2018) Higher anti-cytomegalovirus immunoglobulin G concentrations are associated with worse neurocognitive performance during suppressive antiretroviral therapy. Clin Infect Dis 67(5):770\u2013777","journal-title":"Clin Infect Dis"},{"issue":"3","key":"126_CR138","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s13365-015-0406-3","volume":"22","author":"AJ Levine","year":"2016","unstructured":"Levine AJ, Quach A, Moore DJ, Achim CL, Soontornniyomkij V, Masliah E et al (2016) Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders. J Neurovirol 22(3):366\u2013375","journal-title":"J Neurovirol"},{"issue":"2","key":"126_CR139","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAI.0000000000001371","volume":"75","author":"AJ Levine","year":"2017","unstructured":"Levine AJ, Martin E, Sacktor N, Munro C, Becker J, For the multicenter ACS-NWG (2017) Predictors and impact of self-reported suboptimal effort on estimates of prevalence of HIV-associated neurocognitive disorders. J Acquir Immune Defic Syndr 75(2):203\u2013210","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"126_CR140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/QAI.0b013e3182237e54","volume":"57","author":"JL Lyons","year":"2011","unstructured":"Lyons JL, Uno H, Ancuta P, Kamat A, Moore DJ, Singer EJ et al (2011) Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr 57(5):371\u2013379","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"126_CR141","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s13365-015-0382-7","volume":"22","author":"Q Ma","year":"2016","unstructured":"Ma Q, Vaida F, Wong J, Sanders CA, Kao Y-T, Croteau D et al (2016) Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol 22(2):170\u2013178","journal-title":"J Neurovirol"},{"issue":"41","key":"126_CR142","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1523\/JNEUROSCI.1287-16.2016","volume":"36","author":"MK Mamik","year":"2016","unstructured":"Mamik MK, Asahchop EL, Chan WF, Zhu Y, Branton WG, McKenzie BA et al (2016) Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV\/AIDS neurodegeneration. J Neurosci 36(41):10683\u201310695","journal-title":"J Neurosci"},{"issue":"5","key":"126_CR143","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/cid\/ciw328","volume":"63","author":"MJ Marquine","year":"2016","unstructured":"Marquine MJ, Montoya JL, Umlauf A, Fazeli PL, Gouaux B, Heaton RK et al (2016) The Veterans Aging Cohort Study (VACS) Index and neurocognitive change: a longitudinal study. Clin Infect Dis 63(5):694\u2013702","journal-title":"Clin Infect Dis"},{"issue":"1","key":"126_CR144","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jneuroim.2004.08.026","volume":"157","author":"E Masliah","year":"2004","unstructured":"Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A et al (2004) Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol 157(1):163\u2013175","journal-title":"J Neuroimmunol"},{"issue":"4","key":"126_CR145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s13365-015-0333-3","volume":"21","author":"JL McGuire","year":"2015","unstructured":"McGuire JL, Gill AJ, Douglas SD, Kolson DL (2015) Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol 21(4):439\u2013448","journal-title":"J Neurovirol"},{"issue":"1","key":"126_CR146","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1570162X13666150121111548","volume":"13","author":"S Mediouni","year":"2015","unstructured":"Mediouni S, Jablonski J, Paris JJ, Clementz MA, Thenin-Houssier S, McLaughlin JP et al (2015) Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice. Curr HIV Res 13(1):64\u201379","journal-title":"Curr HIV Res"},{"key":"126_CR147","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1742-2094-9-239","volume":"9","author":"R Mehla","year":"2012","unstructured":"Mehla R, Bivalkar-Mehla S, Nagarkatti M, Chauhan A (2012) Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator. J Neuroinflammation 9:239","journal-title":"J Neuroinflammation"},{"issue":"1","key":"126_CR148","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-017-0848-z","volume":"14","author":"SR Mehta","year":"2017","unstructured":"Mehta SR, P\u00e9rez-Santiago J, Hulgan T, Day TRC, Barnholtz-Sloan J, Gittleman H et al (2017) Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. J Neuroinflammation 14(1):72","journal-title":"J Neuroinflammation"},{"issue":"6","key":"126_CR149","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13365-014-0283-1","volume":"20","author":"KA Meulendyke","year":"2014","unstructured":"Meulendyke KA, Queen SE, Engle EL, Shirk EN, Liu J, Steiner JP et al (2014) Combination fluconazole\/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease. J Neurovirol 20(6):591\u2013602","journal-title":"J Neurovirol"},{"issue":"6","key":"126_CR150","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF03210850","volume":"16","author":"MM Mielke","year":"2010","unstructured":"Mielke MM, Bandaru VVR, McArthur JC, Chu M, Haughey NJ (2010) Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus. J Neurovirol 16(6):445\u2013456","journal-title":"J Neurovirol"},{"issue":"2","key":"126_CR151","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/QAI.0000000000000677","volume":"70","author":"A Moulignier","year":"2015","unstructured":"Moulignier A, Gueguen A, Lescure F-X, Ziegler M, Girard P-M, Cardon B et al (2015) Does HIV infection alter Parkinson disease? J Acquir Immune Defic Syndr 70(2):129\u2013136","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"40","key":"126_CR152","doi-asserted-by":"crossref","first-page":"34976","DOI":"10.1074\/jbc.M111.241547","volume":"286","author":"R Mukerjee","year":"2011","unstructured":"Mukerjee R, Chang JR, Del Valle L, Bagashev A, Gayed MM, Lyde RB et al (2011) Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem 286(40):34976\u201334985","journal-title":"J Biol Chem"},{"issue":"2","key":"126_CR153","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000001362","volume":"75","author":"SS Mukerji","year":"2017","unstructured":"Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons J, Chalkias S et al (2017) Temporal patterns and drug resistance in CSF viral escape among ART-experienced HIV-1 infected adults. J Acquir Immune Defic Syndr 75(2):246\u2013255","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"126_CR154","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/cid\/ciy267","volume":"67","author":"SS Mukerji","year":"2018","unstructured":"Mukerji SS, Misra V, Lorenz DR, Uno H, Morgello S, Franklin D et al (2018) Impact of antiretroviral regimens on cerebrospinal fluid viral escape in a prospective multicohort study of antiretroviral therapy-experienced human immunodeficiency virus-1\u2013infected adults in the United States. Clin Infect Dis 67(8):1182\u20131190","journal-title":"Clin Infect Dis"},{"issue":"2","key":"126_CR155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003829","volume":"10","author":"EA Mutlu","year":"2014","unstructured":"Mutlu EA, Keshavarzian A, Losurdo J, Swanson G, Siewe B, Forsyth C et al (2014) A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog 10(2):e1003829","journal-title":"PLoS Pathog"},{"issue":"6","key":"126_CR156","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13365-014-0279-x","volume":"20","author":"LC Ndhlovu","year":"2014","unstructured":"Ndhlovu LC, Umaki T, Chew GM, Chow DC, Agsalda M, Kallianpur KJ et al (2014) Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND). J Neurovirol 20(6):571\u2013582","journal-title":"J Neurovirol"},{"issue":"1","key":"126_CR157","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/QAD.0000000000002042","volume":"33","author":"MJ Nichols","year":"2019","unstructured":"Nichols MJ, Gates TM, Soares JR, Moffat KJ, Rae CD, Brew BJ et al (2019) Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection. AIDS 33(1):55\u201366","journal-title":"AIDS"},{"issue":"11","key":"126_CR158","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","volume":"13","author":"S Nightingale","year":"2014","unstructured":"Nightingale S, Winsto A, Letendre S, Michael BD, McArthur JC, Khoo S et al (2014) Controversies in HIV-associated neurocognitive disorders. Lancet Neurol 13(11):1139\u20131151","journal-title":"Lancet Neurol"},{"issue":"3","key":"126_CR159","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s13365-019-00723-4","volume":"25","author":"TM Nir","year":"2019","unstructured":"Nir TM, Jahanshad N, Ching CRK, Cohen RA, Harezlak J, Schifitto G et al (2019) Progressive brain atrophy in chronically infected and treated HIV+ individuals. J Neurovirol 25(3):342\u2013353","journal-title":"J Neurovirol"},{"issue":"9","key":"126_CR160","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/QAD.0000000000002236","volume":"33","author":"J O\u2019Halloran","year":"2019","unstructured":"O\u2019Halloran J, Cooley SA, Strain JF, Boerwinkle A, Paul R, Presti RM et al (2019) Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors. AIDS 33(9):1477","journal-title":"AIDS"},{"issue":"1","key":"126_CR161","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12977-018-0401-x","volume":"15","author":"M Ogishi","year":"2018","unstructured":"Ogishi M, Yotsuyanagi H (2018) Prediction of HIV-associated neurocognitive disorder (HAND) from three genetic features of envelope gp120 glycoprotein. Retrovirology 15(1):12","journal-title":"Retrovirology"},{"issue":"1","key":"126_CR162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006112","volume":"13","author":"MF Oliveira","year":"2017","unstructured":"Oliveira MF, Chaillon A, Nakazawa M, Vargas M, Letendre SL, Strain MC et al (2017) Early antiretroviral therapy is associated with lower HIV DNA molecular diversity and lower inflammation in cerebrospinal fluid but does not prevent the establishment of compartmentalized HIV DNA populations. PLoS Pathog 13(1):e1006112","journal-title":"PLoS Pathog"},{"issue":"5","key":"126_CR163","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jcp.24254","volume":"228","author":"M Pacifici","year":"2013","unstructured":"Pacifici M, Delbue S, Ferrante P, Jeansonne D, Kadri F, Nelson S et al (2013) Cerebrospinal fluid miRNA profile in HIV-encephalitis. J Cell Physiol 228(5):1070\u20131075","journal-title":"J Cell Physiol"},{"key":"126_CR164","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nature25140","volume":"553","author":"D Palesch","year":"2018","unstructured":"Palesch D, Bosinger SE, Tharp GK, Vanderford TH, Paiardini M, Chahroudi A et al (2018) Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV host. Nature 553:77","journal-title":"Nature"},{"issue":"7","key":"126_CR165","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2012-03-414706","volume":"120","author":"I Pandrea","year":"2012","unstructured":"Pandrea I, Cornell E, Wilson C, Ribeiro RM, Ma D, Kristoff J et al (2012) Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood 120(7):1357\u20131366","journal-title":"Blood"},{"unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of Antiretroviral agents in adults and adolescents living with HIV. Department of Health and Human Services. Available at http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf. Accessed 30 July 2019","key":"126_CR2"},{"doi-asserted-by":"crossref","unstructured":"Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A et al (2012) Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well-controlled plasma viral load. AIDS (London, England) 26(14)","key":"126_CR166","DOI":"10.1097\/QAD.0b013e328355e6b2"},{"issue":"11","key":"126_CR167","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/infdis\/jit088","volume":"207","author":"MJ Peluso","year":"2013","unstructured":"Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC et al (2013) Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis 207(11):1703\u20131712","journal-title":"J Infect Dis"},{"issue":"3","key":"126_CR168","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1386-6532(01)00196-2","volume":"22","author":"LA Pemberton","year":"2001","unstructured":"Pemberton LA, Brew BJ (2001) Cerebrospinal fluid S-100\u03b2 and its relationship with AIDS dementia complex. J Clin Virol 22(3):249\u2013253","journal-title":"J Clin Virol"},{"issue":"5","key":"126_CR169","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0002-9440(10)65476-4","volume":"155","author":"Y Persidsky","year":"1999","unstructured":"Persidsky Y, Ghorpade A, Rasmussen J, Limoges J, Liu XJ, Stins M et al (1999) Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 155(5):1599\u20131611","journal-title":"Am J Pathol"},{"issue":"12","key":"126_CR170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116081","volume":"9","author":"J Peterson","year":"2014","unstructured":"Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L et al (2014) Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One 9(12):e116081","journal-title":"PLoS One"},{"issue":"7","key":"126_CR171","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.neurobiolaging.2014.01.008","volume":"35","author":"A Pfefferbaum","year":"2014","unstructured":"Pfefferbaum A, Rogosa DA, Rosenbloom MJ, Chu W, Sassoon SA, Kemper CA et al (2014) Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study. Neurobiol Aging 35(7):1755\u20131768","journal-title":"Neurobiol Aging"},{"issue":"10","key":"126_CR172","first-page":"844","volume":"3","author":"A Pfefferbaum","year":"2018","unstructured":"Pfefferbaum A, Zahr NM, Sassoon SA, Kwon D, Pohl KM, Sullivan EV (2018) Accelerated and premature aging characterizing regional cortical volume loss in human immunodeficiency virus infection: contributions from alcohol, substance use, and hepatitis C coinfection. Biol Psychiatry 3(10):844\u2013859","journal-title":"Biol Psychiatry"},{"issue":"2","key":"126_CR173","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s13365-018-0696-3","volume":"25","author":"TA Premeaux","year":"2019","unstructured":"Premeaux TA, D\u2019Antoni ML, Abdel-Mohsen M, Pillai SK, Kallianpur KJ, Nakamoto BK et al (2019) Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. J Neurovirol 25(2):150\u2013161","journal-title":"J Neurovirol"},{"key":"126_CR174","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s13365-018-0695-4","volume":"25","author":"L Pulliam","year":"2019","unstructured":"Pulliam L, Sun B, Mustapic M, Chawla S, Kapogiannis D (2019) Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer\u2019s disease. J Neurovirol 25:702\u2013709","journal-title":"J Neurovirol"},{"issue":"3","key":"126_CR175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s13365-018-0625-5","volume":"24","author":"A Quach","year":"2018","unstructured":"Quach A, Horvath S, Nemanim N, Vatakis D, Witt MD, Miller EN et al (2018) No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV. J Neurovirol 24(3):350\u2013361","journal-title":"J Neurovirol"},{"issue":"1","key":"126_CR176","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00126334-200405010-00003","volume":"36","author":"KR Robertson","year":"2004","unstructured":"Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG et al (2004) Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 36(1):562\u2013566","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"14","key":"126_CR177","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","volume":"21","author":"KR Robertson","year":"2007","unstructured":"Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J et al (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21(14):1915\u20131921","journal-title":"AIDS"},{"issue":"5","key":"126_CR178","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","volume":"18","author":"K Robertson","year":"2012","unstructured":"Robertson K, Liner J, Meeker RB (2012) Antiretroviral neurotoxicity. J Neurovirol 18(5):388\u2013399","journal-title":"J Neurovirol"},{"issue":"2","key":"126_CR179","volume":"11","author":"W Royal III","year":"2016","unstructured":"Royal W III, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J et al (2016) Associations between cognition, gender and monocyte activation among HIV infected individuals in Nigeria. PLoS One 11(2):e0147182","journal-title":"PLoS One"},{"issue":"12","key":"126_CR180","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/QAD.0000000000001858","volume":"32","author":"LH Rubin","year":"2018","unstructured":"Rubin LH, Sacktor N, Creighton J, Du Y, Endres CJ, Pomper MG et al (2018) Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy. AIDS (London, England) 32(12):1661\u20131667","journal-title":"AIDS (London, England)"},{"issue":"12","key":"126_CR181","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.0b013e31822f0412","volume":"77","author":"N Sacktor","year":"2011","unstructured":"Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen BA et al (2011) Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. Neurology 77(12):1135\u20131142","journal-title":"Neurology"},{"issue":"6","key":"126_CR182","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s13365-014-0292-0","volume":"20","author":"N Sacktor","year":"2014","unstructured":"Sacktor N, Miyahara S, Evans S, Schifitto G, Cohen B, Haughey N et al (2014) Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV seropositive individuals with cognitive impairment. J Neurovirol 20(6):620\u2013626","journal-title":"J Neurovirol"},{"issue":"4","key":"126_CR183","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1212\/WNL.0000000000002277","volume":"86","author":"N Sacktor","year":"2016","unstructured":"Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E et al (2016) Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology 86(4):334\u2013340","journal-title":"Neurology"},{"issue":"1","key":"126_CR184","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13365-017-0587-z","volume":"24","author":"N Sacktor","year":"2018","unstructured":"Sacktor N, Skolasky RL, Moxley R, Wang S, Mielke MM, Munro C et al (2018) Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial. J Neurovirol 24(1):16\u201327","journal-title":"J Neurovirol"},{"issue":"1","key":"126_CR185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/QAI.0000000000000779","volume":"71","author":"N Sailasuta","year":"2016","unstructured":"Sailasuta N, Ananworanich J, Lerdlum S, Sithinamsuwan P, Fletcher JLK, Tipsuk S et al (2016) Neuronal-glia markers by magnetic resonance spectroscopy in HIV before and after combination antiretroviral therapy. J Acquir Immune Defic Syndr 71(1):24\u201330","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"126_CR186","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.neuint.2011.02.004","volume":"58","author":"ZM Saiyed","year":"2011","unstructured":"Saiyed ZM, Gandhi N, Agudelo M, Napuri J, Samikkannu T, Reddy PVB et al (2011) HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND). Neurochem Int 58(6):656\u2013664","journal-title":"Neurochem Int"},{"key":"126_CR187","doi-asserted-by":"crossref","first-page":"e2542","DOI":"10.1038\/cddis.2016.467","volume":"8","author":"A Sami Saribas","year":"2017","unstructured":"Sami Saribas A, Cicalese S, Ahooyi TM, Khalili K, Amini S, Sariyer IK (2017) HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity. Cell Death Dis 8:e2542","journal-title":"Cell Death Dis"},{"issue":"4","key":"126_CR188","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M et al (2016) HIV-associated neurocognitive disorder \u2013 pathogenesis and prospects for treatment. Nat Rev Neurol 12(4):234\u2013248","journal-title":"Nat Rev Neurol"},{"issue":"13","key":"126_CR189","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/01.wnl.0000268487.78753.0f","volume":"69","author":"G Schifitto","year":"2007","unstructured":"Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, Millar LL et al (2007) A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology 69(13):1314\u20131321","journal-title":"Neurology"},{"issue":"4","key":"126_CR190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000395","volume":"5","author":"G Schnell","year":"2009","unstructured":"Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R (2009) Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1\u2013associated dementia. PLoS Pathog 5(4):e1000395","journal-title":"PLoS Pathog"},{"issue":"2","key":"126_CR191","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116526","volume":"10","author":"RD Schrier","year":"2015","unstructured":"Schrier RD, Hong S, Crescini M, Ellis R, P\u00e9rez-Santiago J, Spina C et al (2015) Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV Associated Neurocognitive Disorders (HAND). PLoS One 10(2):e0116526","journal-title":"PLoS One"},{"issue":"10","key":"126_CR192","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2174\/1381612811319100010","volume":"19","author":"M Serena","year":"2013","unstructured":"Serena M, Stefano S, Oriana T (2013) Blocking HIV-1 replication by targeting the Tat-hijacked transcriptional machinery. Curr Pharm Des 19(10):1860\u20131879","journal-title":"Curr Pharm Des"},{"issue":"1","key":"126_CR193","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.64.1.97","volume":"64","author":"JJ Sevigny","year":"2007","unstructured":"Sevigny JJ, Albert SM, McDermott MP et al (2007) An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol 64(1):97\u2013102","journal-title":"Arch Neurol"},{"issue":"1","key":"126_CR194","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1742-2094-7-96","volume":"7","author":"A Shah","year":"2010","unstructured":"Shah A, Kumar A (2010) HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-\u03baB pathway and can be silenced by gp120-specific siRNA. J Neuroinflammation 7(1):96","journal-title":"J Neuroinflammation"},{"issue":"1","key":"126_CR195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbrc.2011.09.033","volume":"414","author":"A Shah","year":"2011","unstructured":"Shah A, Singh DP, Buch S, Kumar A (2011a) HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-\u03baB pathway. Biochem Biophys Res Commun 414(1):112\u2013117","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"126_CR196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021261","volume":"6","author":"A Shah","year":"2011","unstructured":"Shah A, Verma AS, Patel KH, Noel R, Rivera-Amill V, Silverstein PS et al (2011b) HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA. PLoS One 6(6):e21261","journal-title":"PLoS One"},{"issue":"6","key":"126_CR197","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/infdis\/161.6.1068","volume":"161","author":"S Shaunak","year":"1990","unstructured":"Shaunak S, Albright RE, Klotman ME, Henry SC, Bartlett JA, Hamilton JD (1990) Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J Infect Dis 161(6):1068\u20131072","journal-title":"J Infect Dis"},{"issue":"3","key":"126_CR198","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s13365-017-0523-2","volume":"23","author":"DP Sheppard","year":"2017","unstructured":"Sheppard DP, Iudicello JE, Morgan EE, Kamat R, Clark LR, Avci G et al (2017) Accelerated and accentuated neurocognitive aging in HIV infection. J Neurovirol 23(3):492\u2013500","journal-title":"J Neurovirol"},{"issue":"9","key":"126_CR199","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","volume":"24","author":"S Simioni","year":"2010","unstructured":"Simioni S, Cavassini M, Annoni J-M, Abraham AR, Bourquin I, Schiffer V et al (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24(9):1243\u20131250","journal-title":"AIDS"},{"issue":"10","key":"126_CR200","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1086\/379038","volume":"188","author":"KK Singh","year":"2003","unstructured":"Singh KK, Barroga CF, Hughes MD, Chen J, Raskino C, McKinney RE et al (2003) Genetic influence of CCR5, CCR2 and SDF1 variants on human immunodeficiency virus 1 (HIV-1)\u2013related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. J Infect Dis 188(10):1461\u20131472","journal-title":"J Infect Dis"},{"issue":"1","key":"126_CR201","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QAD.0000000000000511","volume":"29","author":"M Somsouk","year":"2015","unstructured":"Somsouk M, Estes JD, Deleage C, Dunham RM, Albright R, Inadomi JM et al (2015) Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS 29(1):43\u201351","journal-title":"AIDS"},{"issue":"1","key":"126_CR202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/187152612798994939","volume":"12","author":"M Sonia","year":"2012","unstructured":"Sonia M, Albert D, Gilbert B, Isabelle R, Catherine D, Herve T-D et al (2012) Antiretroviral therapy does not block the secretion of the human immunodeficiency virus Tat protein. Infect Disord Drug Targets 12(1):81\u201386","journal-title":"Infect Disord Drug Targets"},{"issue":"10","key":"126_CR203","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/QAD.0b013e328339e25c","volume":"24","author":"SA Spector","year":"2010","unstructured":"Spector SA, Singh KK, Gupta S, Cystique LA, Jin H, Letendre S et al (2010) 195APOE \u03b54 and MBL-2 O\/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors from Anhui Province, China. AIDS 24(10):1471\u20131479","journal-title":"AIDS"},{"issue":"5","key":"126_CR204","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/jir387","volume":"204","author":"S Spudich","year":"2011","unstructured":"Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B et al (2011) Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis 204(5):753\u2013760","journal-title":"J Infect Dis"},{"issue":"8","key":"126_CR205","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI127413","volume":"129","author":"S Spudich","year":"2019","unstructured":"Spudich S, Robertson KR, Bosch RJ, Gandhi RT, Cyktor JC, Mar H et al (2019) Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance. J Clin Invest 129(8):3339\u20133346","journal-title":"J Clin Invest"},{"issue":"3","key":"126_CR206","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ene.12006","volume":"20","author":"F Steinbrink","year":"2013","unstructured":"Steinbrink F, Evers S, Buerke B, Young P, Arendt G, Koutsilieri E et al (2013) Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration. Eur J Neurol 20(3):420\u2013428","journal-title":"Eur J Neurol"},{"key":"126_CR207","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2011.05.015","volume":"1399","author":"M Strazza","year":"2011","unstructured":"Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR (2011) Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res 1399:96\u2013115","journal-title":"Brain Res"},{"issue":"Pt 12","key":"126_CR208","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1099\/vir.0.070318-0","volume":"95","author":"SL Strickland","year":"2014","unstructured":"Strickland SL, Rife BD, Lamers SL, Nolan DJ, Veras NMC, Prosperi MCF et al (2014) Spatiotemporal dynamics of simian immunodeficiency virus brain infection in CD8(+) lymphocyte-depleted rhesus macaques with neuroAIDS. J Gen Virol 95(Pt 12):2784\u20132795","journal-title":"J Gen Virol"},{"issue":"3","key":"126_CR209","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004720","volume":"11","author":"CB Sturdevant","year":"2015","unstructured":"Sturdevant CB, Joseph SB, Schnell G, Price RW, Swanstrom R, Spudich S (2015) Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog 11(3):e1004720","journal-title":"PLoS Pathog"},{"issue":"2","key":"126_CR210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11481-013-9495-z","volume":"9","author":"H-S Suh","year":"2014","unstructured":"Suh H-S, Gelman BB, Lee SC (2014a) Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment. J Neuroimmune Pharmacol 9(2):117\u2013132","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"126_CR211","volume":"9","author":"H-S Suh","year":"2014","unstructured":"Suh H-S, Lo Y, Choi N, Letendre S, Lee SC (2014b) Evidence of the innate antiviral and neuroprotective properties of progranulin. PLoS One 9(5):e98184","journal-title":"PLoS One"},{"issue":"14","key":"126_CR212","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1097\/QAD.0000000000001595","volume":"31","author":"B Sun","year":"2017","unstructured":"Sun B, Dalvi P, Abadjian L, Tang N, Pulliam L (2017) Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV. AIDS 31(14):F9\u2013F17","journal-title":"AIDS"},{"issue":"6","key":"126_CR213","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410390606","volume":"39","author":"K Takahashi","year":"1996","unstructured":"Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD (1996) Localization of HIV-1 in human brain using polymerase chain reaction\/in situ hybridization and immunocytochemistry. Ann Neurol 39(6):705\u2013711","journal-title":"Ann Neurol"},{"issue":"6","key":"126_CR214","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/313810","volume":"30","author":"G Tambussi","year":"2000","unstructured":"Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L, Morandini B et al (2000) Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis 30(6):962\u2013965","journal-title":"Clin Infect Dis"},{"issue":"4","key":"126_CR215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010337","volume":"5","author":"ET Tatro","year":"2010","unstructured":"Tatro ET, Scott ER, Nguyen TB, Salaria S, Banerjee S, Moore DJ et al (2010) Evidence for alteration of gene regulatory networks through microRNAs of the HIV-infected brain: novel analysis of retrospective cases. PLoS One 5(4):e10337","journal-title":"PLoS One"},{"key":"126_CR216","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/1471-2334-14-386","volume":"14","author":"ET Tatro","year":"2014","unstructured":"Tatro ET, Soontornniyomkij B, Letendre SL, Achim CL (2014) Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir. BMC Infect Dis 14:386","journal-title":"BMC Infect Dis"},{"issue":"2","key":"126_CR217","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1570162X12666140526114956","volume":"12","author":"E Tavazzi","year":"2014","unstructured":"Tavazzi E, Morrison D, Sullivan P, Morgello S, Fischer T (2014) Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Curr HIV Res 12(2):97\u2013110","journal-title":"Curr HIV Res"},{"issue":"12","key":"126_CR218","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/QAD.0000000000000706","volume":"29","author":"AD Thames","year":"2015","unstructured":"Thames AD, Briones MS, Magpantay LI, Martinez-Maza O, Singer EJ, Hinkin CH et al (2015) The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS 29(12):1483\u20131491","journal-title":"AIDS"},{"issue":"4","key":"126_CR219","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ajpath.2011.06.039","volume":"179","author":"KA Thompson","year":"2011","unstructured":"Thompson KA, Cherry CL, Bell JE, McLean CA (2011) Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. Am J Pathol 179(4):1623\u20131629","journal-title":"Am J Pathol"},{"issue":"5","key":"126_CR220","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1212\/WNL.0b013e3181b04b0d","volume":"73","author":"S Tisch","year":"2009","unstructured":"Tisch S, Brew B (2009) Parkinsonism in HIV-infected patients on highly active antiretroviral therapy. Neurology 73(5):401\u2013403","journal-title":"Neurology"},{"issue":"13","key":"126_CR221","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/mds.23277","volume":"25","author":"S Tisch","year":"2010","unstructured":"Tisch S, Brew BJ (2010) HIV, HAART, and Parkinson\u2019s disease: co-incidence or pathogenetic link? Mov Disord 25(13):2257\u20132258","journal-title":"Mov Disord"},{"issue":"1","key":"126_CR222","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1741-7015-9-138","volume":"9","author":"C Torti","year":"2011","unstructured":"Torti C, Foc\u00e0 E, Cesana BM, Lescure FX (2011) Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? BMC Med 9(1):138","journal-title":"BMC Med"},{"issue":"8","key":"126_CR223","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1089\/aid.2005.21.706","volume":"21","author":"V Tozzi","year":"2005","unstructured":"Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P et al (2005) Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retrovir 21(8):706\u2013713","journal-title":"AIDS Res Hum Retrovir"},{"issue":"8","key":"126_CR224","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","volume":"4","author":"A Trickey","year":"2017","unstructured":"Trickey A, May MT, Vehreschild J-J, Obel N, Gill MJ, Crane HM et al (2017) Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 4(8):e349\u2013ee56","journal-title":"Lancet HIV"},{"key":"126_CR225","first-page":"1","volume":"4","author":"RS Turner","year":"2016","unstructured":"Turner RS, Chadwick M, Horton WA, Simon GL, Jiang X, Esposito G (2016) An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. Alzheimers Dement 4:1\u20135","journal-title":"Alzheimers Dement"},{"issue":"5","key":"126_CR226","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/01.WNL.0000134665.58343.8D","volume":"63","author":"V Valcour","year":"2004","unstructured":"Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O et al (2004) Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63(5):822\u2013827","journal-title":"Neurology"},{"issue":"2","key":"126_CR227","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","volume":"206","author":"V Valcour","year":"2012","unstructured":"Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D et al (2012) Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis 206(2):275\u2013282","journal-title":"J Infect Dis"},{"issue":"7","key":"126_CR228","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070164","volume":"8","author":"VG Valcour","year":"2013","unstructured":"Valcour VG, Ananworanich J, Agsalda M, Sailasuta N, Chalermchai T, Schuetz A et al (2013) HIV DNA reservoir increases risk for cognitive disorders in cART-Na\u00efve patients. PLoS One 8(7):e70164","journal-title":"PLoS One"},{"issue":"4","key":"126_CR229","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s13365-013-0181-y","volume":"19","author":"M Vassallo","year":"2013","unstructured":"Vassallo M, Dunais B, Durant J, Carsenti-Dellamonica H, Harvey-Langton A, Cottalorda J et al (2013) Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study. J Neurovirol 19(4):376\u2013382","journal-title":"J Neurovirol"},{"issue":"7","key":"126_CR230","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/hiv.12246","volume":"16","author":"M Vassallo","year":"2015","unstructured":"Vassallo M, Durant J, Lebrun-Frenay C, Fabre R, Ticchioni M, Andersen S et al (2015) Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation. HIV Med 16(7):431\u2013440","journal-title":"HIV Med"},{"doi-asserted-by":"crossref","unstructured":"Veenstra M, Le\u00f3n-Rivera R, Li M, Gama L, Clements JE, Berman JW (2017) Mechanisms of CNS viral seeding by HIV+ CD14+ CD16+ monocytes: establishment and reseeding of viral reservoirs contributing to HIV-associated neurocognitive disorders. MBio 8(5)","key":"126_CR231","DOI":"10.1128\/mBio.01280-17"},{"key":"126_CR232","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11481-018-9792-7","volume":"14","author":"M Veenstra","year":"2019","unstructured":"Veenstra M, Byrd DA, Inglese M, Buyukturkoglu K, Williams DW, Fleysher L et al (2019) CCR2 on peripheral blood CD14+CD16+ monocytes correlates with neuronal damage, HIV-associated neurocognitive disorders, and peripheral HIV DNA: reseeding of CNS reservoirs? J Neuroimmune Pharmacol 14:120\u2013133","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"126_CR233","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/QAD.0000000000001379","volume":"31","author":"NJ Venkatachari","year":"2017","unstructured":"Venkatachari NJ, Jain S, Walker L, Bivalkar-Mehla S, Chattopadhyay A, Bar-Joseph Z et al (2017) Transcriptome analyses identify key cellular factors associated with HIV-1 associated neuropathogenesis in infected men. AIDS 31(5):623\u2013633","journal-title":"AIDS"},{"issue":"15","key":"126_CR234","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0000000000002485","volume":"86","author":"JH Vera","year":"2016","unstructured":"Vera JH, Guo Q, Cole JH, Boasso A, Greathead L, Kelleher P et al (2016) Neuroinflammation in treated HIV-positive individuals: a TSPO PET study. Neurology 86(15):1425\u20131432","journal-title":"Neurology"},{"issue":"13","key":"126_CR235","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.0b013e3181f4d5bb","volume":"75","author":"P Vivithanaporn","year":"2010","unstructured":"Vivithanaporn P, Heo G, Gamble J, Krentz H, Hoke A, Gill M et al (2010) Neurologic disease burden in treated HIV\/AIDS predicts survival a population-based study. Neurology 75(13):1150\u20131158","journal-title":"Neurology"},{"issue":"4","key":"126_CR236","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/QAD.0000000000000955","volume":"30","author":"P Vivithanaporn","year":"2016","unstructured":"Vivithanaporn P, Asahchop EL, Acharjee S, Baker GB, Power C (2016) HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance. AIDS (London, England) 30(4):543\u2013552","journal-title":"AIDS (London, England)"},{"issue":"7","key":"126_CR237","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/glia.20801","volume":"57","author":"R Williams","year":"2009","unstructured":"Williams R, Dhillon NK, Hegde ST, Yao H, Peng F, Callen S et al (2009) Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes. Glia 57(7):734\u2013743","journal-title":"Glia"},{"issue":"7","key":"126_CR238","volume":"8","author":"DW Williams","year":"2013","unstructured":"Williams DW, Calderon TM, Lopez L, Carvallo-Torres L, Gaskill PJ, Eugenin EA et al (2013) Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis. PLoS One 8(7):e69270","journal-title":"PLoS One"},{"issue":"5","key":"126_CR239","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1212\/01.wnl.0000252811.48891.6d","volume":"68","author":"M Wong","year":"2007","unstructured":"Wong M, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E et al (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68(5):350\u2013355","journal-title":"Neurology"},{"issue":"5","key":"126_CR240","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/13803390903264130","volume":"32","author":"SP Woods","year":"2010","unstructured":"Woods SP, Iudicello JE, Dawson MS, Weber E, Grant I, Letendre SL et al (2010) HIV-associated deficits in action (verb) generation may reflect astrocytosis. J Clin Exp Neuropsychol 32(5):522\u2013527","journal-title":"J Clin Exp Neuropsychol"},{"issue":"7","key":"126_CR241","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1017\/S1355617717000431","volume":"23","author":"SP Woods","year":"2017","unstructured":"Woods SP, Iudicello JE, Morgan EE, Verduzco M, Smith TV, Cushman C et al (2017) Household everyday functioning in the internet age: online shopping and banking skills are affected in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc 23(7):605\u2013615","journal-title":"J Int Neuropsychol Soc"},{"issue":"10","key":"126_CR242","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/WNL.0b013e3181f11bd8","volume":"75","author":"EJ Wright","year":"2010","unstructured":"Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP et al (2010) Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology 75(10):864\u2013873","journal-title":"Neurology"},{"issue":"4","key":"126_CR243","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/QAD.0000000000000560","volume":"29","author":"PW Wright","year":"2015","unstructured":"Wright PW, Vaida FF, Fern\u00e1ndez RJ, Rutlin J, Price RW, Lee E et al (2015) Cerebral white matter integrity during primary HIV infection. AIDS 29(4):433\u2013442","journal-title":"AIDS"},{"issue":"8","key":"126_CR244","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/QAD.0000000000001778","volume":"32","author":"EJ Wright","year":"2018","unstructured":"Wright EJ, Grund B, Robertson KR, Cysique L, Brew BJ, Collins GL et al (2018) No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts. AIDS 32(8):985\u2013997","journal-title":"AIDS"},{"issue":"5","key":"126_CR245","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s13365-016-0433-8","volume":"22","author":"A Yadav","year":"2016","unstructured":"Yadav A, Betts MR, Collman RG (2016) Statin modulation of monocyte phenotype and function: implications for HIV-1 associated neurocognitive disorders. J Neurovirol 22(5):584\u2013596","journal-title":"J Neurovirol"},{"issue":"9","key":"126_CR246","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1038\/cddis.2010.56","volume":"1","author":"SV Yelamanchili","year":"2010","unstructured":"Yelamanchili SV, Chaudhuri AD, Chen LN, Xiong H, Fox HS (2010) MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV\/HIV neurological disease. Cell Death Dis 1(9):e77","journal-title":"Cell Death Dis"},{"issue":"1","key":"126_CR247","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-2094-10-62","volume":"10","author":"A Yilmaz","year":"2013","unstructured":"Yilmaz A, Yiannoutsos CT, Fuchs D, Price RW, Crozier K, Hagberg L et al (2013) Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. J Neuroinflammation 10(1):62","journal-title":"J Neuroinflammation"},{"issue":"18","key":"126_CR248","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.0000000000000932","volume":"83","author":"AC Young","year":"2014","unstructured":"Young AC, Yiannoutsos CT, Hegde M, Lee E, Peterson J, Walter R et al (2014) Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology 83(18):1592\u20131600","journal-title":"Neurology"},{"issue":"10","key":"126_CR249","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/QAD.0000000000001481","volume":"31","author":"C Yu","year":"2017","unstructured":"Yu C, Seaton M, Letendre S, Heaton R, Al-Harthi L (2017) Plasma dickkopf-related protein 1, an antagonist of the Wnt pathway, is associated with HIV-associated neurocognitive impairment. AIDS 31(10):1379\u20131385","journal-title":"AIDS"},{"issue":"2","key":"126_CR250","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s13365-013-0150-5","volume":"19","author":"L Yuan","year":"2013","unstructured":"Yuan L, Qiao L, Wei F, Yin J, Liu L, Ji Y et al (2013) Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. J Neurovirol 19(2):144\u2013149","journal-title":"J Neurovirol"},{"issue":"1","key":"126_CR251","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/QAI.0000000000001466","volume":"76","author":"T Yuen","year":"2017","unstructured":"Yuen T, Brouillette M-J, Fellows LK, Ellis RJ, Letendre S, Heaton R et al (2017) Personalized risk index for neurocognitive decline among people with well-controlled HIV infection. J Acquir Immune Defic Syndr 76(1):48\u201354","journal-title":"J Acquir Immune Defic Syndr"},{"key":"126_CR252","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.04.001","volume":"1458","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Wang M, Li H, Zhang H, Shi Y, Wei F et al (2012) Accumulation of nuclear and mitochondrial DNA damage in the frontal cortex cells of patients with HIV-associated neurocognitive disorders. Brain Res 1458:1\u201311","journal-title":"Brain Res"},{"issue":"1","key":"126_CR253","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1186\/1471-2164-13-677","volume":"13","author":"L Zhou","year":"2012","unstructured":"Zhou L, Pupo GM, Gupta P, Liu B, Tran SL, Rahme R et al (2012) A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genomics 13(1):677","journal-title":"BMC Genomics"}],"container-title":["Current Topics in Behavioral Neurosciences","Neurocognitive Complications of HIV-Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2019_126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T11:08:53Z","timestamp":1635505733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2019_126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030807580","9783030807597"],"references-count":253,"URL":"https:\/\/doi.org\/10.1007\/7854_2019_126","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"type":"print","value":"1866-3370"},{"type":"electronic","value":"1866-3389"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"11 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}